Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial-Reference-Cited by-同舟云学术

Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial

Published:2009-01 Issue:7 Volume:44 Page:853-860
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Haukeland John Willy,Konopski Zbigniew,Eggesbø Heidi Beate,von Volkmann Hilde Løland,Raschpichler Gabriele,Bjøro Kristian,Haaland Terese,Løberg Else Marit,Birkeland Kåre

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

http://www.tandfonline.com/doi/pdf/10.1080/00365520902845268

Reference24 articles.

1. Nonalcoholic Fatty Liver Disease

2. Non-alcoholic fatty liver disease

3. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

4. Long-term follow-up of patients with NAFLD and elevated liver enzymes

5. A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

3. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

4. Effects of black mulberry leaf extract on liver health and metabolic parameters in rats with high-fat diet-induced liver changes;Obesity Medicine;2024-09

5. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?;Metabolism;2024-08